These results suggested that NFATc1 and DDIAS in cancer cells contribute to high STAT3 levels and resistance to gefitinib and that DGG-100629 induces PDC apoptosis by downregulating DDIAS expression and suppressing STAT3 signaling. Here, STAT3 is linked to cancer.